The Centers for Disease Control and Prevention has updated respiratory syncytial virus vaccination recommendations for adults 60 and older. Adults aged 60-74 at increased risk for RSV and all aged 75 and older are recommended a single dose of the GSK, Pfizer or Moderna vaccine. Individuals who previously received a dosage should not seek another. 

Related News Articles

Headline
The San Francisco Department of Public Health Jan. 10 announced a presumptive positive case of H5N1 bird flu in a child after they experienced symptoms of…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Louisiana Department of Health yesterday announced that a patient hospitalized last month for H5N1 bird flu has died, becoming the first U.S. death from…
Headline
AHA’s latest social media toolkit for encouraging vaccination against the flu and COVID-19 focuses on vaccination during peak respiratory virus season. The…
Headline
The Department of Health and Human Services Jan. 3 announced it is awarding approximately $306 million to support the federal government’s H5N1 bird flu…
Headline
The California Department of Public Health Saturday reported the first known case of clade I mpox in the U.S. to the Centers for Disease Control and Prevention…